Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 10849849 Subcutaneous HER2 antibody formulations

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 30 Oct, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 30 Oct, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 12128103 Adjuvant treatment of HER2-positive breast cancer
0
Edits on 9 Oct, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 9 Oct, 2024
Edits on 29 May, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 29 May, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11992529 Adjuvant treatment of HER2-positive breast cancer
0
Edits on 24 May, 2023
"update inverses"
Golden AI profile picture
Golden AI
edited on 24 May, 2023
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11655305 Treatment of metastatic breast cancer
0
"update inverses"
Golden AI profile picture
Golden AI
edited on 24 May, 2023
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11654105 Subcutaneous HER2 antibody formulations
0
Edits on 19 May, 2023
"Remove website redirecting to Patent Public Search front page"
Golden AI profile picture
Golden AI
edited on 19 May, 2023
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=1084984900
Edits on 3 May, 2023
"update inverses"
Golden AI profile picture
Golden AI
edited on 3 May, 2023
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11638756 Adjuvant treatment of HER2-positive breast cancer
0
Edits on 23 Apr, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 23 Apr, 2023
Edits on 26 Mar, 2023
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 26 Mar, 2023
Infobox
Is a
Patent
Patent
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
108498490
Date of Patent
December 1, 2020
0
Patent Application Number
158726480
Date Filed
January 16, 2018
0
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=108498490
Patent Citations
‌
US Patent 10160811 Treatment with anti-ErbB2 antibodies
0
‌
US Patent 10280228 Treatment with anti-ErbB2 antibodies
0
‌
US Patent 10385405 Gene expression markers of tumor resistance to HER2 inhibitor treatment
0
‌
US Patent 10689457 Treatment of metastatic breast cancer
0
Patent Citations Received
‌
US Patent 11414498 Composition comprising antibody that binds to domain II of HER2 and acidic variants thereof
0
‌
US Patent 11597776 Composition comprising antibody that binds to domain II of HER2 and acidic variants thereof
0
Patent Primary Examiner
‌
Hong Sang
0
Edits on 8 Mar, 2023
"update inverses"
Golden AI profile picture
Golden AI
edited on 8 Mar, 2023
Edits on 26 Sep, 2022
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 26 Sep, 2022
Edits on 23 Sep, 2022
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 23 Sep, 2022
Edits on 17 Aug, 2022
"update inverses"
Golden AI profile picture
Golden AI
edited on 17 Aug, 2022
Edits on 17 Jun, 2022
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 17 Jun, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
https://pdfpiw.uspto.gov/.piw?Docid=10849849
Edits on 8 Feb, 2022
"Created via: Entity Importer"
Golden AI profile picture
Golden AI
created this topic on 8 Feb, 2022
Edits made to:
Infobox (+11 properties)
‌

 US Patent 10849849 Subcutaneous HER2 antibody formulations

Infobox
Is a
Patent
Patent
Patent jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent number
10849849
Date of patent
December 1, 2020
Patent application number
15872648
Date Filed
January 16, 2018
Patent citations
‌
US Patent 10160811 Treatment with anti-ErbB2 antibodies
‌
US Patent 10280228 Treatment with anti-ErbB2 antibodies
‌
US Patent 10385405 Gene expression markers of tumor resistance to HER2 inhibitor treatment
‌
US Patent 10689457 Treatment of metastatic breast cancer
Patent primary examiner
‌
Hong Sang

Find more entities like US Patent 10849849 Subcutaneous HER2 antibody formulations

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo